3P BIOTECH NORWAY AS: årsregnskap 2018 vs 2017
Shrank 27% on revenue, cash halved-plus
approved 2019-06-30; registry 2019-07-23; journal 2019 771333
Summary
What changed
Comparing Årsregnskap 2018 with 2017 for 3P BIOTECH NORWAY AS. Revenue 36.6k NOK → 26.6k NOK (-27.3%). Equity 476.2k NOK → 382.3k NOK.
Pressures included: revenue fell; operating result weakened; equity eroded.
Also worth watching: book investments changed. All figures are taken from the published annual accounts for 3P BIOTECH NORWAY AS.
At a glance
Scorecard
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 36.6k NOK to 26.6k NOK (-27.3% YoY). Calculated
-
↓
Operating result weakened
Operating result +18.3k NOK → +8 740 NOK (op. margin 50.0% → 32.9%). Calculated
-
↓
Equity eroded
Book equity 476.2k NOK → 382.3k NOK (equity ratio 289.0% → 23.4%). Calculated
-
↓
Cash fell
Bank deposits 338.6k NOK → 11.6k NOK (-96.6% YoY). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 2.17× → 0.77× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
Things to notice
-
·
Book investments changed
Investment / intangible book value 96.1k NOK → 70.8k NOK. Reported fact